Picard Medical files resale prospectus for up to 16.2M shares by selling stockholders; company gets no proceeds

Filed June 1, 2026 · ~1 min read

Key Changes

• high

  The prospectus covers resale of up to 16,211,479 shares by selling stockholders, including warrants, QC shares, and Sindex shares.

  The Offering verify on EDGAR →
• high

  This is a secondary offering; Picard Medical will not receive any proceeds from these sales.

  The Offering verify on EDGAR →
• medium

  Selling stockholders include WestPark Capital and Brandon Ross holding Placement Agent Warrants with exercise price $0.229 per share, expiring five years from issuance.

  The Offering verify on EDGAR →